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The 3rd meeting of the European Social Forum was held in London during October 
2004 with a broad ranging formal agenda and a penumbra of  affiliated workshops 
and cultural activities. This paper focuses upon a range of sessions dealing with 
science in general and the sciences of human genetics in particular. Through 
participant observation this paper details the representations of science by ESF actors, 
their use of the ESF as a ‘convergence space’ for  global activist network interaction 
and the various ways in which participants sought to create a more socially 
responsible and accountable science.  
 
Drawing on observations of, and participation in, these sessions we describe how 
scientific knowledge and practices were portrayed in the context of neo-liberal market 
relations by both ‘producers’ and ‘consumers’ of techno-science. The concluding 
section considers the implications of (re)negotiating scientific and social orders within 
such open network spaces.  It is argued that ‘broad and shallow’ and ‘narrow and 
deep’ approaches towards public understanding of science need to be supplemented 
by the ‘broad and diverse’ processes typifying the forum milieu. 
 
Key Words:  Science, Genomics, Globalisation, World Social Forum,  European 
Social Forum, Complexity.  
 
Introduction 
In October 2004 London hosted the third annual meeting of the European Social 
Forum (ESF), one of several geo-political regional assemblies constituted as part of 
the World Social Forum (WSF). Organised under the banner ‘Another World is 
Possible’, the meeting emphasised the need to promote peace, democracy, justice, 
human rights, and sustainability whilst resisting racism, discrimination, privatisation, 
deregulation, globalisation and neo-liberalism. Given these emphases it is not 
surprising that concerns around science, technology, innovation and their role in 
supporting Western lifestyles and institutions were strongly represented in the 
programme. The question these workshops and seminars raised reflected these 
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concerns by asking, if another world is possible, does this mean that another science is 
needed and, if so, what should it look like? 
 
In this article we present one of the first attempts to track debates about science within 
a single ESF meeting. We concentrate on two sets of workshops and seminars: the 
first addressed ‘science and citizens’ in fairly general terms; the second focussed on 
developments within human genetics. Drawing on insights from Science and 
Technology Studies (STS) and Social Movement Studies, we examine how the social 
sciences can use ethnographic methods to engage with emergent forms of social 
action that remains invisible to research methods and projects that only collect data 
after the stakes and organisations have formalised. The analysis thus emphasises two 
interwoven themes.  
 
The first is an examination of the stakes and stakeholders associated with science and 
genomics. Based on our observations we outline the anatomy of the emerging politics 
of science and genomics displayed at the London ESF. In doing so, we emphasise the 
relationship between the ‘producers’ and ‘consumers’ of scientific knowledge and the 
tensions over the ‘ownership’ and ‘control’ of knowledge and its application. These 
categories reflect both the primary frames of engagement used in many of the 
observed sessions and the key analytic terms used to address interest representation 
within pluralist approaches to democratic inclusion. Whilst these terms originated in 
relation to material products, their use in relation to biological process and associated 
‘immaterial’ concerns enables us to address within a consistent framework those 
aspects of genomics that are likely to become central to public negotiations about 
developments in this field.  
 
Secondly, the development of both material and immaterial stakes are situated within 
the growth of the social forum movement itself. Here, the importance of network 
forms reinforcing the ‘strength of weak ties’ (Granovetter 1973) operating within 
‘small world networks’ (Chesters and Welsh 2005, 2005a, Urry 2003) are used to 
highlight the way social forum events such as the London ESF need to be understood 
as part of a global and nested network including Peoples’ Global Action and the 
World Social Forum. This networked movement milieu links an increasing number of 
‘hubs’ operating at city, national, and regional levels through regular ‘protest’ and 
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proactive capacity building events (Chesters & Welsh 2005a, Sen 2004). These 
processes, which have been operating since the late 1990s as a ‘shadow realm’ (Welsh 
2002), are consistent with a ‘latency period’ (Melucci 1996) within which collective 
stakes, which pre-figure and partially constitute grievance frames, are declared. At the 
London ESF, the engagement of these actors with science issues sui generis and 
genomic issues in particular marks a significant ‘phase shift’ in terms of activist and 
citizen engagement with science. In effect, activists used the ESF as ‘convergence 
space’ (Routledge 2003) to develop horizontal networks, linking existing actors with 
new groups and individuals whilst also developing new strategies and organisations 
for lobbying and more direct forms of action.2 Given the dominance of governance 
and civil society approaches to ‘inclusionary’ science policy, and the proliferation of 
techniques designed to orchestrate citizen involvement (see for example the EU 
‘Science and Society’ forum held in Brussels in March 2005 
www.europa.eu.int/comm/research/conferences/2005/forum2005 ), this focus on the 
periphery is a timely reminder that democracy happens outside as well as inside 
formal institutions and processes. 
 
The ESF thus constituted a point of critical contrast between the orchestrated public 
surface of debates around science and genomics and the views present within a milieu 
with a relatively high density of ‘informed’ and / or engaged actors. Our anatomy of 
these interactions thus have implications for both the structure and content of ‘citizen 
science’ at the national and EU levels in the context of global civil society networks. 
We return to these global themes in our conclusions where we argue that the social 
forum movement represents an accumulating social force pursuing’ public interest 
science’ as a response to neo-liberalism. In order for us to make this argument, 
however, it is important to start at the beginning and provide a brief summary of the 
origins and development of the social forum movement at global and regional levels.  
The Social Forum Movement 
The WSF was first conceived in 1996 during discussions between activists and 
academics at the Tricontinental Centre in Belgium (Chesters and Welsh 2005a)4. 
                                                 
2 The founding  of the ESSF (European Science Social Forum) network during the ESF is the most 
prominent example of this. The ESF web site can be found at www.fse-esf.org . 
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Convened for the first time at Porto Allegro in Brazil in 2001 the WSF is a self 
conscious focus for global civil society concerns raised by neo-liberal globalisation 
and promoted by institutions such as the World Economic Forum (WEF). The WSF’s 
annual meetings in ‘the South’ coincide with those of WEF and Social Forums 
aligned with the declared Charter of Principles have been convened in Asia, Africa, 
the Americas and Europe promoting the formation of numerous urban social forums 
within specific nations3.  
 
The network agency of Peoples’ Global Action and other global civil society 
advocates within the ‘Alternative Globalisation Movement’ have made the Social 
Forum a dynamic and expanding ‘bottom up’ movement (Fischer & Panniah 2003). A 
sense of this vibrancy can be derived from the first European Social Forum held in 
Florence during 2002. At least 30,000 participants attended the event, which offered 
an extensive programme of seminars, workshops and plenaries addressing every 
imaginable policy domain relevant to an economic society. The event confounded 
fears of a repeat of the violence in Genoa in 2001 when the so called ‘anti-
globalisation movement’ sought to disrupt the G8 summit The Paris ESF in 2003 
attracted an estimated 20,000 paying delegates and an unknown number of ‘casual’ 
participants in over 1,000 dedicated sessions. The London ESF replicated both the 
form and content of previous events, with the official programme containing over a 
thousand sessions in many different venues and styles that offered the estimated 
25,000 participants4 wide-ranging opportunities for education, capacity building and 
networking. 
Distinctive Features of the London ESF 
Like all expressions of global network actors (Welsh 2004) the local ‘UK’ context 
shaped the event, giving it a distinctive feel and organisation. These ‘localised’ socio-
cultural dynamics were most clearly visible within the social geography (Routlege 
2003) of the ESF meetings and the three tier structure that emerged. The main London 
                                                 
3 . In the UK standing urban social forums include Leeds, Manchester, Oxford, Bristol and Cardiff. All 
urban social forums are required to endorse the principles of the WSF and become part of a radiating 
hub and spoke structure predicated upon consensus decision making. The charter of principles can be 
accessed via www.forumsocialmundial.org . 
4  Pre-registration figures by nation were Belgium 593, France 1003, Germany 834, Greece 363, Italy 
1,362, Poland 499, Russia 190 and Spain 1,271 (Callanicos 2004). 
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venue at Alexandra Palace staged the major set piece debates and seminars, 
‘affiliated’ events occupied a series ‘autonomous venues’ in central London whilst 
‘independent autonomous’ events were convened at a variety of locations across 
London. Many of the autonomous events continued themes initiated in previous ESF 
events and were organised through e-mail lists and peer networks. Their location in 
‘autonomous space’ thus reflects organisational dynamics we address below but also 
underlines the continued relevance of a ‘shadow realm’ open to scrutiny only through 
‘network immergence’ and not available to those relying solely on the official 
programme. 
 
This tripartite organisation was the product of an extended period of heated 
‘negotiation’ between three key constituencies: the Mayor of London, Ken 
Livingston, and key Trade Unions mobilised significant funds and personnel; the 
Socialist Workers Party and its ‘front’ organisations, Globalise Resistance and 
Respect, represented a second significant constituency; whilst the third key 
constituency was the diverse grouping of NGOs, social movement actors and network 
movements (Callanicos 2004 for a ‘vertical’ account). The last grouping was certainly 
the most diverse, containing varying degrees of libertarian orientation ranging from 
consensus based direct action communities to formal NGOs such as Greenpeace with 
relatively strong ties to the processes of institutional change  
 
In organising the UK forum the differences between these constituencies became 
polarised in a division between ‘verticals’ (i.e. official programme see Callanicos 
2004) and ‘horizontals’ (i.e. autonomous programmes). Some sense of the protracted 
nature of the negotiating process can be gleaned from the fact that the ‘affiliated 
autonomous’ events were only included in the official programme at the last minute 
amidst denunciations of the ESF as a reformist initiative by some London based direct 
action groups. Some horizontals networks formed at previous ESF events booked 
alternative venues independently, having become frustrated by the difficulties of 
dealing with the formal organising structures. For participants, however, these 
distinctions were neither rigid nor impermeable and people moved more or less freely 
between official and affiliated events listed in the main programme, whilst those with 
pre-existing network links dipped into both the independent and official programmes.  
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Methodological Issues 
Despite the permeability of the vertical-vs-horizontal split in practice, the distinction 
between ‘affiliated’ and ‘independent’ autonomous spheres remains important. For 
example, because the independently convened autonomous events were absent from  
the main programme they were invisible to academic studies based on published 
information. In this sense, and despite their increasing public visibility, key parts of 
social forums are still best understood as a ‘shadow realm’ (Welsh 2002) despite 
increasing social scientific engagement5.  
 
Based on previous experiences at ESF meetings, we ‘sampled’ the ESF programme 
by following a single issue through different kinds of meeting. The selection of 
science and human genetics as our focus reflected ongoing research into public 
engagement with genomic science.6 Sessions within the published programme 
relating to public engagement with science sui generis were identified, as were all 
sessions explicitly related to human genomics. In addition, the researchers’ network 
contacts created a presence at specific independently organised sessions. 
 
The majority of  sessions were attended by one or two team members and data was 
gathered through participant observation. Whilst the convenors of all the genetics 
sessions were aware of the presence of researchers, for other participants and the 
convenors of the generic science sessions the work was effectively covert as, even 
when the researchers contributed to discussions, something consistent with the 
overriding participatory ethos of the forum, they did not declare the specific nature of 
their research interests. In the longer term this will enable the tracking of specific 
interventions through subsequent network iterations, a practice analogous to the 
introduction of information in reconvened focus group work. This provides a practical 
means of engaging in subsequent network mapping through continued participation in 
email lists originating in ESF meetings. Sustained engagement within such lists thus 
                                                 
5  A range of research instruments were being used within the ESF including self administered 
questionnaires left in meeting rooms from Alan Touraine’s centre in Paris as well as a number of other 
‘teams’ immersed within the sprawling forum process without any clear ‘sampling strategy’.  




becomes one means of tracking the network extensions constituting the forum milieu 
as a shadow realm.  
 
Following the ESF meeting, field notes and reflections on official, affiliated and 
independent events were typed up and triangulated with documentary, web based and 
previously garnered interview data. It is important to emphasise that the data gathered 
and discussed here reflect the views of critically informed constituencies such as 
disability rights and social justice activists. As such the constituency sampled might 
be usefully conceived of as a ‘critical sub-group’ in a manner analogous to the 
designation of ‘critical groups’ within risk assessments. Groups and organisations that 
might be more supportive of the technology, such as patient groups or research 
charities, were not prominently represented at the ESF.8  
 
In this context, our aims are two-fold. First, to explore the ideas about and the 
contextualisation of ‘science’ in the sessions we attended and, in particular, to 
examine the views of the ‘producers’ and ‘consumers’ of science present. These 
categories arise from the dominant identifications made by the participants but it is 
important to emphasise that they are not mutually exclusive. Both ‘scientists’ and 
‘citizens’ were present within the opposite majorities marking the presence of both 
‘citizen science’ and the ‘scientific citizen’. In what follows, we outline debates as 
they occurred within the ‘Citizens and Science’ sessions and then the ‘Human 
Genetics’ workshops. In each case, we summarise the main arguments put forward 
and provide some critical commentary on the ideas and stakes embedded in them. 
Secondly, we elaborate the network implications of the declared stakes observed 
identifying similarities and differences and outlining some of the main challenges that 
lie ahead for activists in both streams. 
                                                 
8 Initial research  reinforces Welsh’s (2000) point that ‘pro’ and ‘anti’ formalisations oversimplify portrayals 
of issues within science controversies; a process intensified by the complexity of interactions and 
techniques associated with human genetic technologies. Ethnographic mapping of public engagement on 
the ‘emerging politics’ project is not confined to critical actors and interviews have been conducted with 
several ‘prime movers’ in ‘pro’ genetics networks. See Plows (2004) 
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Producers of Science and Scientific Citizenship   
The official programme contained an ambitious programme of workshops and 
seminars addressing the need for both citizens and scientists to have more opportunity 
to shape research agendas and, by implication, guide them in a more socially 
responsible direction. As shown below, the discussions ranged from the viability of 
citizen assemblies on science to the contractual conditions under which many 
scientists work. These meetings were scheduled throughout the three days of the ESF 
and culminated in a well resourced final session replete with multilingual translation. 
Each of the sessions we attended is described below. 
What Research Policies Are Appropriate in Another Europe? 
Despite a notice postponing this session about a dozen people, including the 
researchers, turned up anyway and the meeting eventually ‘self convened’. The 
ensuing discussion of ‘Research Policies for Another Europe’ thus operated in an 
autonomous manner, with the problems and potential solutions it identified arising 
independently of any framing work by the convening organisations. As such the 
issues raised represent an interesting counter-point to the ‘convened’ sessions held 
later, which were all led, and thus to some extent framed, by formal presentations 
from invited speakers. 
 
The discussion framed EU science as directed towards securing economic 
competitiveness and hence as a strategic part of political and economic policy within 
a global neo-liberal system. The impact of these overarching themes within both 
Higher Education and the wider scientific research community formed an important 
element of the discussions, which emphasised the increasing role of private funding in 
Universities; the imposition of flexible labour market conditions, notably short-term 
contracts for the scientific workforce; the need to integrate social science and 
humanities disciplines within the policy process; the need for clear science 
communication and public dissemination; and the need to link university based 
science with ‘local knowledge generation’. 
 
In many cases, the resolution of these problems was seen as providing greater public 
control over science, with discussion revolving around issues of public representation 
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within science policy formulation; the accountability of the policy process itself; the 
priorities expressed in existing EU science policy commitments, most notably the 
‘science and society’ programme established during the EU funding of Framework 6, 
and developing prominence within the research priorities of Framework 7 (the Lisbon 
agenda). In general, the discussion was characterised by a determined attempt to work 
within the WSF leitmotif ‘Another World is Possible’ and identify some specific 
policies that would be compatible with this aim. The outcome was a clear emphasis 
on locating EU science policy within a global context, addressing the ‘needs’ of both 
the industrialised ‘north ’and the ‘emergent’ south. In particular, key ideas that 
emerged were: 
 
• Promoting sustainable development to address immediate social needs by 
prioritising locally defined stakes; 
• Reform of labour market conditions within the EU science-base to reduce the 
influence of private funding coupled with an increase in citizen influence on 
policy agendas; 
• The need for permanently constituted local feedback mechanisms to secure 
public input as an iterative phenomenon. 
 
Science and Citizenship 
Although initially scheduled as two separate sessions, Science and Citizenship was 
actually organised as a single session and without the advertised speakers from 
Demos and Greenpeace. In contrast to the ‘Research Policies’ session, this panel was 
organised as a conventional ‘speeches and questions’ session in which speakers from 
unions, critical science associations and professional bodies addressed an audience 
that rose from about 50 to about 100 as the session progressed. 
 
The opening address emphasised the centrality of scientific and technological 
innovation to social and economic change, the emancipatory role of science since the 
17th century, and the traditional association between ‘neutral’ scientific knowledge 
and progress. These themes were then juxtaposed with recent controversies 
(Chernobyl, BSE, GMOs and infected blood supplies), the short termism associated 
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with private capital’s need to secure prompt returns on investment, and the 
‘penetration’ of both public and private domains by techno-scientific agendas. A 
progressive response required the ‘social control of science via scientific citizenship’ 
and the plethora of ‘experiments’ in this area (particularly those modelled on the 
Danish Consensus Conference) were noted but it was also emphasised that there was 
still work to be done in developing both the ‘concepts’ and the ‘tools’ needed to 
advance this agenda. 
 
The second speaker was Werner Braun, speaking as a previous Director of The 
International Network of Engineers and Scientists for Global Responsibility (INES 
www.inesglobal.com ) and member of the Max Plank Institute. Starting from the view  
that ‘neo-liberalism destroys society, cultures and nature’, he argued that the ‘nucleus’ 
of critical scientists from the 1968 generation must be transformed into the ‘critical 
mass’ needed for a globally responsible science. Interestingly, the main issues 
formalised corresponded quite closely to those raised in the self-organising session 
described above: the corporate appropriation of University research agendas; insecure 
labour markets for the two million EU science work force; dominant military R & D 
agendas and profit orientation were all identified as key areas to be addressed. 
 
The discussion was not limited to abstractions and generalities, however, and several 
specific policies were proposed. These included an end to military R & D; the 
expansion in Peace and Ecological Research, the introduction of Institutes of 
Technical Assessment, the democratisation of R & D structures, the need for more 
social research and the transfer of skills into new sectors via labour migration. It was 
also emphasised that this agenda applied only to the ‘developed’ world and that 80 – 
90% of the worlds’ population – including Russia and much of Eastern Europe - lay 
outside this sphere.  
 
The extension of critical science engagement to these wider constituencies was 
portrayed as a goal of future ESF events, which should seek to expand ‘critical 
science content’ through a ‘coalition of engaged scientists and citizens’. Key here 
would be a programme of action relating to the patenting of genetic material, the 
ending of military research and alternative models for financing scientific work. An 
immediate measure to be pursued would be the institution of a ten percent working 
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time allocation for ethical reflection, public engagement and inter-disciplinary 
orientation for working scientists. Increasing the normative standing of University 
sector scientists working with NGOs such as Greenpeace10 as a redress to prevailing 
norms of collaborating with the corporate sector was also advocated.  
 
The second main speaker highlighted many of the same themes whilst also reflecting 
on the development of critical science issues within the ESF, beginning with the 
launch of ‘Science for the People’ during the Florence ESF (see Science For The 
People , 1, 2002 13-14). Rather than highlighting abstract principles, she used her 
own biography to exemplify the issues raised in other sessions. Despite holding a PhD 
in Medical Science, she had decided to become a school teacher as she knew that, 
because of the labour market conditions, her ‘family prospects would otherwise be 
zero’. The presentation emphasised the ‘double economic burden’ arising from 
simultaneous public and private expenditure on projects such as the mapping of the 
human genome and the consequent effects on basic research, which was effectively 
marginalised by the search for short-term profit. Social control over science was 
needed and could be achieved by combining the skills of the scientific labour force 
with the social programmes of the trade unions. The existence of a ‘public will’ in this 
area was illustrated by a demonstration of 300,000 people over public policy and 
science in the Netherlands on October 2nd 2004.  
 
Subsequent discussions generally confirmed the speakers’ analysis although some 
concerns about the practical possibilities of ring-fenced time for ethical science within 
the private sector were raised. Comparisons were drawn between previous sessions  in 
Florence and Paris with the increased attendance in London being noted. INES  called 
for the coordination of initiative by scientists across Europe to create a ‘network that 
can mobilise in physical space’. The ESF session thus also facilitated an important 
moment of capacity building and network consolidation as participants from all the 
major contributors to the European science base became party to subsequent e-mail 
lists, wiki and web sites that emerged from the initiative. In addition, there were 
numerous bilateral exchanges of web site and e-mail details as the meeting adjourned 
                                                 
10 Greenpeace UK maintains a research capacity at Exeter University. 
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and the ‘informal’ work familiar to academic conference circles began in earnest. The 
involvement in these networks of academic and scientific unions from the UK, 
France, Spain, Italy and Germany suggests an active phase of network extension.  
A European Science Social Forum 
The final session addressing ‘science in general’ was held on the Sunday morning at 9 
a.m.6 It was clearly conceived as the grand finale, with a sizeable platform of 
speakers representing the key constituencies. Interestingly, and perhaps because of 
this, the tone adopted by some of the speakers was very different, particularly in their 
characterisation of science, from the other two sessions.  
 
The opening address was given by the Vice President of the AUT. Starting from the 
view that ‘science is about facts not values’, he argued that European academic 
research was prioritising ‘quantity over quality’, something exemplified by the UK’s  
Research Assessment Exercise. These views were reinforced by the first speaker, 
Janine Guespin, who potrayed the EU’s 6th Framework Programme as an 
‘unaccountable’ project ‘conceived by experts’ which intensified the commodification 
of science by harnessing it to the economic and political goals of neo-liberalism. She 
described how an insecure and fragmented French scientific workforce had lobbied 
for ‘legal rights’ within the EU, a struggle in which stronger links to citizens through 
attention to wider issues were urgently needed. 
 
The realist view of science implicit in the opening remarks re-emerged starkly in the 
second presentation by Claus Monton, which was introduced as being about ‘hard 
science’ not ‘social science’. The hard sciences were a ‘success story’ based on 
professional hierarchies rather than ‘democracy’ with experimental replication 
providing ‘the best means of conclusive proof generation’ revealing universal laws 
and cutting across ‘inter-subjectivity’. Whilst it was acknowledged that science could 
squander societal resources (via Jonas 1985, Habermas, 2003) and in cases like 
climate change, trigger potentially irreversible processes, the overall message was 
clear. In science ‘another world is not possible’ and it was therefore important to 
reassert its autonomy.  
 15
 
Given this view, the role and place of citizens in the scientific enterprise required 
careful consideration. The EU’s abstract commitment to citizen participation had to be 
supported but any citizen control must be in a ‘velvet glove’. In practice this meant 
open peer reviewing, avoiding ‘standpoint’ science and protecting scientists prepared 
to act ethically and speak out in public. In other words, the goal should be to restore 
and maintain the autonomy enjoyed by science and considered central to innovation 
and progress. Whilst there was support for ‘citizens advisory boards’ to ‘harness 
support for decisions taken elsewhere’ the place of ‘citizens assemblies within the R 
& D process’ raised the questions of ‘how much power’ they should hold. 
 
Claudia Neubauer, speaking on behalf of the Paris based Citizen Science Foundation 
and a later active in the ESSF network that emerged from the London meeting, used 
her address to introduce the themes of inter-generational equity and justice.. 
Significantly these were addressed not as ‘technical choices [but] choices of life’ and 
thus about the kind of use to which science and technology should be put. Rather than 
permitting scientific and technical agendas to drive social change, it was important to 
reverse the causality and ask ‘What kind of society do we want to build and what 
science and technology takes us there?’ All choices come with an opportunity cost 
and the decision to pursue one research programme is invariably a decision not to 
fund several others. Given this, the argument made was that the priorities that shape 
such choices need to be more closely tied to citizen values and preferences. Examples 
of the new practices that might promote these new interactions between scientists and 
citizens included the Canadian Community University Research Societies funded to 
the equivalent of 3m euros p.a., science shops, consensus conferences and citizens 
juries. There was a need for the ‘tools and money to make counter expertise’ available 
and, perhaps most importantly, to explicitly question the assumption of scientific 
autonomy advanced by the earlier speakers. Thus there were calls for increased public 
debate on research budgets and science missions before strategic R & D budgets are 
set, public funding for NGO science, ‘career breaks’ for scientists via secondment to 
NGOs (in part to support the creation of counter expertise) and for corporate science 
based innovation to be exposed to ‘harsh evaluation’ prior to market entry. In making 
                                                                                                                                            
6 Given the extensive social programme available to delegates on Saturday attendance was healthy 
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these arguments, the public were characterised as neither ignorant nor anti-science 
but, instead, as wanting ‘another research – another science’. 
 
David Margolies was introduced as the sole speaker without a background in the 
natural sciences and spoke in his capacity as an AUT representative The relationship 
between neo-liberalism and deregulation was portrayed as contaminating the 
scientific endeavour and workplace in two inter-related ways. In terms of scientific 
endeavour, regulatory standards, particularly those around patenting and intellectual 
property rights, had been determined in global fora such as the WTO to the benefit of 
corporate players on dubious scientific grounds. Secondly, and in many ways 
reinforcing this, the short term contracts and mobility that characterise the upper end 
of the science career structure serve to create a ‘revolving door syndrome’ in which 
government and regulatory scientists routinely move between senior development and 
negotiating posts within the corporate sector. The effect is a relatively a closed circle 
within which a common focus tends to prevail and difficult questions are not asked7. 
Issues of public trust and confidence in science could not be addressed let alone 
resolved whilst these relationships continued and there was an urgent need for an 
adequately resourced independent science base.  
‘Producer’ Views and the Call for Scientific Assemblies  
Although all the sessions observed stressed the need for changes in the way science is 
organised and managed, the final session illustrates the work that will be required if 
scientists themselves are to recognise their own role in creating and sustaining social 
order. The accounts of science by the majority of platform speakers were Mertonian 
in character lacking familiarity with recent work in the sociology of science, 
philosophy of science or the complexity sciences which increasingly regard the 
natural and social sciences as confronting different variants of the same problem set 
(Chesters 2004, Eve, et. al. 1997, Urry, 2003). In particular the presentation of science 
as about  ‘fact’ and ‘truth’ demonstrated no engagement with the notion of science as 
social or cultural knowledge (Barnes, Bloor and Henry 1996, Collins 1992, Latour 
2004) or contemporary debates about ‘post-positivist science’(Fischer 2000). Indeed, 
by the autonomy of science the speakers missed the crucial point of such work, which 
                                                                                                                                            
suggesting a degree of dedication to the network aims. 
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is not that standpoint science is bad, but that all science (irrespective of the perceived 
consequences) is standpoint science. Whilst the political left has traditionally seen the 
rationality and progress associated with science as a means to the end of increasing 
social justice, recognising the links between science and the wider society makes 
these assumptions more problematic (Turner 2003). 
 
The presentation of science as about ‘facts’ and not ‘values’ denies that ‘Another 
World is Possible’ and enables its adherents to skirt around the uncomfortable social 
fact that the meanings attached to observable phenomena vary profoundly from 
culture to culture. One particularly clear example of this provides an appropriate 
bridge to the next section of the paper: whilst healthy embryonic cell divisions occur 
in a universally predictable pattern, different cultures attribute ‘life’ to the cell bundle 
at widely varying times (Romeo-Casabona 2002). This makes stem-cell work 
profoundly challenging in ethical terms for Christian societies, but unproblematic in 
the Muslim world. Given the extension of such differences down to much more 
mundane technical and scientific levels the pursuit of ‘global regulatory reach’ 
(Welsh & Evans 1999, Welsh 2000) will remain profoundly problematic. 
 
Thus, whilst the ESF meeting successfully brought together a range of concerned 
scientists and citizens, the problems and challenges of engaging with the differences 
between even such mutually sympathetic groups of scientific ‘producers’ and 
‘consumers’ remain substantial. Indeed, one of the key challenges facing the ESSF 
network that was formed during the London meeting will be to manage these 
differences in order to lobby the EU to act to limit the power of market mechanisms 
within science and to increase citizen control and scrutiny of its agendas. Whilst these 
activities represent only one outcome of the ESF, they do show how such events 
facilitate the development and co-ordination of actions within and between civil 
society groups. We will return to these themes in the conclusions, but will first 
consider how science and its applications were discussed within the more ‘consumer 
led’ genomics sessions.  
                                                                                                                                            
7 These points are redolent of Bateson’s  (1973) preoccupation with the dangers of ‘habits of mind’ 
 18
Genomics at the London ESF 
In addition to the sessions addressing the relationships between science, the state and 
citizens, there was also a series of workshops examining the same issues but in the 
context of human genomics. Studying the debates as they occurred in these sessions is 
important as it is the application of specific sciences that most citizens ultimately deal 
with. This is why, for example, that support for science in general can be high, whilst 
opposition to specific applications – nuclear power, ‘green genetics’ and so on – can 
be extremely vociferous. In sampling the sessions on medical genetics we were, 
therefore, looking to explore how the abstract notions of choice-vs-control, autonomy-
vs-regulation, good-vs-bad were played on the context of specific applications. 
 
The sessions we attended were all held on the second day of the ESF and were 
organised by a range of NGOs, including Genewatch, The Cornerhouse and Human 
Genetics Alert,  established groups campaigning for greater control and regulation of 
genetic research. The established NGOs and key individuals within recent arrivals, 
such as Human Genetics Alert and GeneWatch had considerable campaigning 
experience in the area of genetically modified crops.12. None of the groups hosting 
workshops had attended earlier ESF events, though genomics had been the subject of 
several sessions in Paris in 2001. Sessions attended were: 
 
• Developments in Human Genetics 
• Bar coding people - Individualised health care or money making scam? 
• Prenatal screening: eugenics or women's rights? 
• Human cloning and genetic engineering: what's at stake? 
 
NGOs had identified biobanks and screening as key issues, reflecting their experience 
of regulatory and consultative processes and the pragmatic need to define realistic 
campaign objectives. The topics chosen for the ESF workshops demonstrate classic 
NGO functions: to research issues, respond to policy/regulatory calls, and perform a 
                                                 
12  As well as the anti GM groups, a variety of other  “early risers”  have engaged in the genomic domain 
as previously constituted networks such as  animal rights groups, pro lifers, patient groups and advocacy 
charities, disability rights groups recognise emergent associated stakes. Pre existing networks are 
predisposed to mobilise most rapidly  in response to new risks/ hopes (Nelkin 1995) making national 
network density a critical factor in emergence.  
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‘public education service’ by disseminating information and highlighting areas of 
controversy8.  
 
It is important point to note that part of this process involves the application of 
familiar grievance claims to emergent phenomena by established actors. Such 
formalised social movement organisations or NGOs pre-date the negotiation and 
declaration of stakes by grass roots actors, underlining the importance attached to 
engaging with social movements from the bottom up by Alan Touraine (Touraine 
1995). Whilst the extension of previous grievance frames is understandable in terms 
of the cross-over between ‘green ’ (agricultural) and ‘red’ (medical) applications of 
genetics the articulation of emergent ‘social movement’ stakes is a process in train, 
constituting a proto-politics in part through the social forum movement. 
 
Compared with the previous sessions the genomics meetings were smaller (15-50 
participants) with some overlap between constituencies, particularly in terms of union 
and INES members. In general, however, the majority of the participants in the 
genomics sessions were interested and concerned citizens and/or activists, some with 
self-declared personal stakes in the issue, rather than the lab workers and scientists 
prominent in earlier sessions. Participants were thus ‘consumers’ of genetic science in 
ways ranging from receiving information within the public sphere to being potential 
recipients of techniques and/or ‘victims’ of genetic testing and discrimination. Most 
of the workshop convenors and speakers were already in network contact with each 
other before the ESF and the appearance of human genetics workshops at the ESF 
provides an important ‘benchmark’ of the level of NGO activity around genetics in 
the UK and EU in the Autumn of 2004.  
 
In contrast to the generally political overtones of the science policy sessions, the 
genetics sessions tended to adopt an introductory and ‘educational’ approach in which 
key issues within genomics were explained and linked to established campaigning 
stances on science and corporate dominance, particularly the role of big 
                                                 
8 These classic goals are shared with the WSF which extends them by declaring its implacable 
opposition to neo-liberalism. 
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pharmaceutical companies9. Given the biographical backgrounds of key contributors 
it is reasonable to argue that the sessions embodied the ‘critical expertise’ called for in 
the producer-led citizen science sessions. Perhaps as a result of this, the general 
tendency in the workshop presentations was to emphasise the indeterminacy of 
scientific knowledge and hence regulatory risks, and the unintended consequences 
associated with it – Beck’s (1992) ‘side effects’. In subsequent discussions 
participants were clearly struggling with ‘boundary issues’, such as what should count 
as an illness that needed to be cured, the appropriate criteria for embryo (de)selection 
and the distinction between medical therapy and genetic enhancement.  
 
As with citizen science sessions, most of the workshops used the standard format of a 
series of speakers, each taking questions at the end of their presentation. Only one 
session departed significantly by asking participants to work through a series of 
structured exercises based on pre-prepared prompts and cue cards. Compared to the 
Paris ESF, where sessions adopted more generic approaches, the London workshops 
effectively marked the ‘arrival’ of human genomics within the social forum process – 
representing a ‘founding moment’ in terms of formulating interest representation 
within the forum milieu.  
Developments in Human Genetics 
The opening session involved four presentations outlining developments in specific 
applications of genetic research, namely genetic testing, pre-natal screening, bio-
banks and forensic uses of ‘genetic fingerprinting’. Speakers located themes relating 
to political, economic, commercial and scientific issues, although in comparison to the 
producer-led session the focus was less on the employment conditions of the scientific 
workers and more on the vulnerability of citizens to ‘near market’ techniques and 
products. The impact of genomic science was thus presented as a node of innovation 
around which a wide variety of interests were clustering with nuclear, pharmaceutical 
and food industries all ‘piling into genetics’ in pursuit of perceived benefits.  As many 
of the themes of subsequent sessions were addressed in this opening session our 
account of the interactions it is more detailed and a more summary approach is 
applied in later sections. 
                                                 
9 This marks a distinct cross-over from previous experience in relation to ‘green’ genomics. 
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Presentation 1: Genetic Testing 
The ability produce individual genetic profiles revealing predispositions’ to specific 
conditions was presented as having implications for lifestyle choices, workplace 
relations and bespoke medical therapies promised by pharmacogenetics. The ways in 
which these developments will be applied was, however, crucial in determining who 
would benefit. For example, in industrial sectors like nuclear and chemical, genetic 
testing could be used to facilitate the selection of ‘hardened’ workers rather than 
improve in environmental standards in the workplace14.  
 
Such promissory futures were however, set in the context of the unreliability of 
genetic testing as a scientific technique. The limitations of current knowledge were 
highlighted using a study showing that only 6 of 600 published links between genes 
and common diseases had proved to be robust (see GeneWatch 2004 citing Hirschorn 
2002). In the remaining 99% of cases there was no ‘clear causality’ arising from a 
genetic component, with environmental interactions being identified as a prime 
complicating factor. Given this ‘weak’ predictive base, the rapid introduction of 
genetic testing was presented as premature and far less certain than statements the 
public domain implied. Instead, the relationship between gene:cell; gene:organ; 
gene:body and gene:environment involved multi-layered causality rather than the 
‘linear causality ‘of genetic determination. This was critiqued as a form of  biological 
reductionism, a theme developed in the Genetic Profiling workshop described below. 
From this standpoint it was important to prevent the generalised use of 
pharmacogenetics before the relationship between genetic, environmental and somatic 
components had been accurately determined and the potential for other approaches 
debated within the wider society. The potential for militaristic applications such as, 
‘hostile control over “ethnic” groups’, was presented as an area of concern despite 
limited prospects for accurate targeting due to the limited genetic variation between 
ethnic groups.   
Presentation 2: Pre-natal Diagnostics 
                                                 
14 The potential of such testing is not limited to overtly hazardous workplaces. Identifying the 20% of the 
population with the potential to readily adapt to night time work patterns associated with the 24/7 society 
would be another potential application. 
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Sangeeta Fager, from the German group ReproKult15, addressed the topic of pre-natal 
diagnostic testing from a ‘feminist’ rather than ‘pro-life’ stance, a crucial distinction 
in terms of legitimacy within the ESF. The issue choices enables by  testing was 
approached as a social issue shaping the opportunities available to women (and to a 
lesser extent, their partners) during pregnancy. Pregnancy was  a ‘social event’ which 
constrained a woman’s agency through the authority of medical experts, who remove 
‘decisional power’ from the woman, and the social and societal inequalities which 
define normative views on reasonable or realistic options. 
 
Although data on pre-natal testing was described as ‘rather limited’, the implications 
of its use were clear and unambiguous. Because the majority of available tests are for 
‘incurable’ conditions a positive result almost inevitably results in termination 
rendering screening as a form of ‘selective eugenics’ (Habermas 2003).  The long 
term use of such tests would thus seem to be a decline in ‘disabled’ human beings as 
part of the human gene pool and culture. The normative acceptance of such practices 
is reinforced by the targeting of ‘benefit levels and availability’ on the ‘healthy’, 
creating the expectation that ‘expensive neo-nates’ will be subject to ‘prompt 
abortion’ in order to maximise the availability of welfare’ provision. 
 
This dystopian vision was juxtaposed with the alternative – electing to continue a 
pregnancy despite the diagnosis of a genetic predisposition. Technically, the weak 
understanding of multi-causality means that a genetic predisposition may never be 
expressed in an adult. But, beyond this, even in conditions such as cystic fibrosis, the 
decision to pursue a pregnancy to term and enter into parenting in order to maximise 
the quality of even a limited life was asserted as a legitimate choice and preference.  
 
In the ensuing discussion, views amongst participants in the session diverged widely. 
One commentator suggested that ‘certain conditions such as cystic fibrosis and male 
haemophilia’ made the idea of ‘test and abort’ unproblematic, whereas others found it 
much harder to define a life as not worth living. More generally, the issue was seen as 
‘human diversity v Barbie’ and it was the ‘social context of capitalism’ that needed to 
be changed as this directed individual choice towards desirable body forms portrayed 
                                                 
15  www.reprokult.de/ 
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within film and media. In the face of this it was important to preserve peoples’ right 
and freedom to exercise negative choice and remain untested.  
Presentation 3: Biobanks 
This presentation described profiling a population through the collection, coding and 
management of genetic data, something which has previously only been attempted 
within relatively isolated gene pools such as Iceland. The compilation of such data 
raises important questions about access, confidentiality, control of information as well 
as potential benefits. In the UK context, these issues were particularly salient given 
the imminent introduction of two Biobank initiatives. The first, UK Biobank, aims to 
assemble data on half a million adults between the ages of 45 and 65 commencing in 
autumn 2005.10 Participants will have a genetic sample taken, give consent for their 
medical records to be accessed and answer a number of life style questions. The other, 
a forensic database, was being created by the police to collate and store genetic 
evidence from crime scenes and suspects. 
 
In describing the UK Biobank, the presentation emphasised the indeterminacy of the 
science behind the project,  focussing upon: the room for human error in mundane 
activities such as data inputting; the variability of medical records in terms of content 
and accuracy and that responses to life style questions tend to exaggerate positive 
elements and under report negative aspects. These are, of course, generic issues 
relevant to data aggregation in general here, which some commentators have 
suggested play a central role in masking complexity effects (Urry 2003). In addition, 
the collection of genetic data also raises more specific problems, with the concept of 
informed consent being particularly problematic in a contexts where the ‘end use was 
not clear’. For example, if data from UK Biobank were made available to 
pharmaceutical companies the question of who owns the data and who profits from 
their exploitation become central issues. This, in turn, raised questions about licensing 
and the appropriate amount of public control over such data should it lead to patented 
products.  
 




Genetic profiling for inclusion in police data bases was also addressed. Although 
genetic profiling has been used to assist in criminal investigations since 1995 the 
concern now was a proposed change to the law that would expand the range of 
circumstances under which compulsory samples can be taken and then kept on file 
irrespective of conviction. The prospect of ‘population level surveys’ by police and 
the possibility of using ‘family traits’ in tracking suspects were also raised. The 
retention of genetic data from unconvicted people in police databases was seen as 
transgressing ‘rights to privacy’ by dissolving traditional public/private boundaries11.  
Presentation 4: Cloning and Genetic Engineering 
In the final presentation, David King of Human Genetics Alert (HGA) introduced 
himself as someone with fifteen years experience in anti-GMO campaigning. Bio-
genetics was presented as driven by neo-liberalism and the ‘push for profit’. 
Reproductive cloning was presented as ‘largely reviled’ and as an area where it was 
important to achieve a ‘global ban’ given the wide ranging opposition to it. In 
contrast, therapeutic cloning was seen as much more problematic from a campaign 
standpoint, with the potential of stem cells to provide cures for currently incurable 
diseases discounted as ‘hyped by scientists and the media’. In his view genetic 
techniques would ‘probably only deliver a small percentage of the promise’ and the 
opportunity cost of continuing this research – as opposed to, for example, increasing 
development aid to in the Third World – was described as ‘obscene’. 
 
As in the second presentation, it was emphasised that concerns about the use of 
embryonic stem cells were not derived from a pro-life stance. Partly this was because 
the standard argument that cloning is ‘unnatural’ is too easy to refute, but also 
because the pro-life stance cannot locate genetic science in its broader political and 
historical context. The key argument was thus that genetics, and in particular 
therapeutic cloning, is part of a much longer trend in the control and domination of 
nature by industrialised capital. As such, the outcome of genetic research is the further 
commodification of natural types and their enhancement to fit the regimes of modern 
industry. By analogy with the development and intensification of agriculture and 
livestock farming, the consequences of the new genetic sciences, should they ever 
                                                 
11 Whether similar concerns should be applied to fingerprints and photographs taken at the time of 
arrest was not addressed. 
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work, will be gradual denial of individual autonomy and freedom and, if we are lucky, 
something akin to Huxley’s Brave New World. More likely, however, was the 
emergence of new forms of stratification and inequality through access to genetic 
enhancements resulting in eugenic forms of social control through individual choices. 
He thus regarded the remit of bioethics s simply too restricted, arguing for a fully 
politicised ethics. 
Follow up actions 
At the end of the session, the e-mail addresses of participants were collected. Unlike 
the previous sessions, where the collection of the list was seen as the start of a 
dialogue, the organisers made it clear that signing up to this list would entail receiving 
‘one e-mail’. The content of this e-mail would provide details of the NGOs and their 
contact information. In this way the potential for network extension which arises 
within many social forum sessions was effectively foreclosed. 
Genetic Profiling session 
This session used a different format by enrolling participants in an exercise based on a 
series of prompts and scenarios that began with a sealed envelope containing ‘their’ 
genetic profile. The first issue raised was whether to open the test result or not. The 
aim here was to highlight the ambiguous status of confidentiality and the potential 
obligation to disclose genetic test results to insurers or other agencies. A minority 
chose not to open the envelope, but those who did found themselves in one of three 
generic profiles ‘A’, ‘B’ and ‘C’. Following this various hypothetical scientific 
breakthroughs and other events were introduced and used to elicit comments and 
stimulate discussion. 
 
The first was a press release from ‘Active Genetics Ltd’, dated October 30th 2004, 
that informed genotype ‘A’ carriers of their vulnerability to heart disease and of a new 
drug, ‘Zapitor’, which ‘has been shown to dramatically reduce the incidence of heart 
disease in later life’. Given knowledge of genotype ‘A’ status the drug ‘Zapitor’ 
promised ‘peace of mind to thousands’, with the obvious implication being that all 
genotype ‘A’ carriers should take Zapitor, with major consequences for both private 
and NHS drug markets. Further genotype specific developments were quick to follow. 
One handbill invited the ‘Tired, Stressed Genotype A’ individual to come to a 
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specialist health farm with ‘10 years experience of preventative treatment’ and enjoy 
the ‘five star menu’ of the resident ‘genotype A qualified chef’. Another detailed the 
use of Zapitor to combat heart disease within genotype ‘B’ when combined with 
dietary and exercise regimes, with the availability of Zapitor as ‘an over-the–counter 
medicine’ portrayed as offering ‘peace of mind for life’, a claim significantly 
qualified in footnotes specifying the size and location of trials, the discounting of 
environmental interactions, notional dose rates based on average body weight (gender 
not specified), and list of known side effects. 
 
Next came a press release from the ‘Genetics Advisory Council’. Headlined ‘Gene 
Testing to be Widely Available’ emphasising the importance of individual ‘choice’ to 
determine ‘their genetic code’ in order to ‘take action to improve their health’. A self-
regulating ‘industry code of practice’, agreed with ‘stakeholders’ and legitimated by a 
‘parliamentary debate’ would ensure that consumers could be confident ‘that tests 
have been properly conducted’. This promotion of self-text was, however, followed 
by a newspaper article, dated March 2005 reporting that  the insurance company ‘Safe 
Hands Ltd.’ had raised premiums for ‘A’ types given their susceptibility to heart 
disease on the grounds that ‘premiums … have always reflected individual risk 
scenarios’. Genotype ‘A’ support groups and individuals expressed concerns about 
the continuing ‘availability of health insurance’ and called for ‘government 
intervention’ to ‘stop genetic discrimination’. 
 
There was no response on this issue from the government, but a Press Release from 
the ‘Department of Homeland Security’ dated August 2005 did announce ‘Genotype 
‘C’ to be electronically tagged’. This followed the discovery by ‘Government 
scientists’ of a ‘strong link’ with ‘higher levels of criminality’. Legislation would be 
introduced for compulsory tagging so that ‘the people of Britain can feel safer on the 
streets and in their homes.’ The labour market implications of this were emphasised in 
an advertisement for an accountant by ‘Blue Sky Thinking’, which ended with the 
simple message ‘Type C Genotype Need not Apply’.  
 
Two more handbills took the scenarios further into the future. An article from ‘The 
Daily Moon’ dated January 2006 revealed ‘Dementia danger for Type As’: Millions 
warned of ticking time bomb in their genes’. The discovery of an ‘increased risk of 
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Alzheimer’s Disease’ meant that ‘Millions . . . face an uncertain future’. Doctors' 
surgeries were ‘swamped with worried patients’ seeking advice confronted by the 
results of a ‘preliminary study’ revealing an ‘increased risk’ that ‘may not be 
significant ’. Guidance offered from the ‘Genes R Us Health Clinic’ advised ‘type As’ 
to take ‘fish oil supplements’ and ‘genetically modified breakfast cereals with 
enhanced omega-3s’. BigPharma Inc called for volunteers for a ‘clinical trial’ of a 
new ‘experimental risk-reducing treatment’. 
 
By 2020 ‘The World Today’ reported ‘growing doubts’ about ‘gene tests and health ’ 
after a five year assessment conducted by the Royal Society. The report ‘found that 
only a tiny minority of studies were robust with most treatments making a negligible 
difference to personal risk. Lifestyle, environment, economic and social factors were 
all ‘more important’ with poverty remaining the ‘world’s biggest killer’. Calls for 
stricter regulation by critical scientists dating from 2004 were noted in the concluding 
section, which closed with a quote from Dr Sue Mayer ‘We told you so’.  
Workshop Dynamics 
As each prompt was introduced, the convenors elicited responses from participants 
whilst introducing their own concerns about the introduction of genomics within a 
neo- liberal context. These concerns included the emphasis on ‘commercial 
exploitation’ and the need to achieve ‘profit streams’ by building demand and markets 
for products rather than engage with scientific attempts to isolate the ‘genetic 
components in causal chains’ which also included ‘environmental elements, toxic 
loads and diet’. As an observer, the session was interesting. The interactions within 
the room were accompanied by much laughter about the stereotypic genetic 
characteristics the session and participants themselves were criticising12. This 
extended to social as well as genetic categories raised in the session with scepticism 
about ‘Big Pharma’ and cynicism of ‘Government’ clearly displayed. Beneath the 
patina of humour the session was unremittingly critical. When this point was raised, 
and the convenor asked directly if the critique of reductionism masked any potential 
benefits that might arise from genetic research, the reply emphasised the adoption of a 
‘product line commitment’ stance rather than addressing ‘more science and 
                                                 
12 Laughter and humour are common social responses to issues with uncomfortable and unpredictable 
implications which evoke ambivalence such as those formalised in this session.  
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complexity’. The tensions between genetic determination and more open ended 
complexity confronting the scientific development of genomics (Wynne 2005) were 
not unpacked despite Genewatch’s considerable expertise. The need to adopt a 
campaigning stance always has implications for the declaratory posture of NGO 
actors leaving the issue of where more open ended issues can and should be addressed 
a challenge for all parties to such contested knowledge domains.   
 
Genewatch’s campaigning stance, centred on the need for independent regulation, in 
the face of rapid marketisation of genetic product streams was the primary organising 
frame structuring the dialogue. As such it was a ‘successful’ exercise conducted with 
a ‘receptive’ audience. The emphasis upon premature commercial exploitation did 
however, preclude addressing the potential for beneficial even critical applications of 
genomic science. The tension between negative critique and constructive critical 
engagement is a well established feature of scientific controversies in which counter 
or critical expertise occupy positions which replicate elements ‘expert / lay’ social 
relations. These are issues we return to in our conclusions.  
Prenatal screening: eugenics or women's rights? 
This, the third session returned to the opening theme, the increased use of pre-natal 
screening and its consequences. Two speakers from the first session, Sangeeta Faber 
and David King, were joined by Ruth Bashall, a disability activist and living 
testament to the viability of disabled life. The session was organised in the standard 
talk and questions format, with the audience of about 20-30. In discussion, however, 
disability activists assumed a prominent role. 
 
Ruth Bashall opened, identifying herself as a woman, a feminist, a lesbian, a person 
with a disability and a campaigner and a grandmother. This emphasis on multiple 
selves and identities is consistent with approaches to citizenship as multi-layered 
consciousness and practice (Turner 2001) constituting a critical civil society (Dryzek 
2000). The underlying notion of ‘life in fragments’ (Bauman 1995, 2000) requiring 
multiple forms of identity work underlines the problematic nature of collective 
identity approaches to new social movements (Stallings 1978, Welsh 1988, McDonald 
2002). Beneath such issues lay several primary foci: the principle that every human 
has equal value; that the birth of every child is valued; and that it is every woman’s 
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right to choose. These points added the difference between medical and social models 
of disability to the obligatory distinction from pro-life positions. Screening was 
addressed in terms of weak prediction with ‘pre-disposition’ not necessarily giving 
rise to full expression. Post-screening power relations were addressed, emphasising 
the illusion of choice in a highly structured and asymmetrical setting where the 
normative expectation is the termination of any ‘risky’ foetus. Sangeeta Faber, of the 
German feminist ReproKult network spoke next, covering much of the same ground 
but also expressing her sense, that by speaking as a ‘healthy’ person she lacked 
authenticity. 
 
The ensuing discussion suggested that at the level of abstraction within the 
presentations did not reflect the sense of a need for action experienced by some 
participants.  A speaker from the ‘People First’ advocacy group pointed out that 
eugenics is happening now and, if screening becomes universal, then the possibility of 
a human mono-culture is increasingly likely. There was therefore a need to move 
beyond defining positions and into organising actions. These might include changing 
the context of screening decisions by requiring more non-medical inputs; (re)training 
the medical profession so that disabilities are no longer seen as ‘diseases’ to be 
‘cured’; encouraging disabled people to educate the able bodied about the reality of 
their lives; active participation in policy consultations and targeted campaigns and 
protests aimed at proponents of screening and the research that makes it possible. 
 
The final speaker, David King,  developed this theme of actions against eugenics. He 
argued that the idea of eugenics had to be used with care. Simple comparisons with 
Nazi-style eugenics and ethnic cleansing invoke images of racism and genocide that 
are both too easy to dismiss and, in any case, miss-represent the ‘real’ story of 
eugenics. Returning to his earlier theme he argued that eugenics is better understood 
as part of the modernist programme of trying to control nature and reduce its 
‘messiness’. Improving the population was seen as a sensible policy in many 
democratic countries and in the early 20th Century, was even supported by proto-
feminist organisations, including what is now the Marie Stopes Institute. 
Contemporary discourses of screening emphasising the reduction or removal of 
suffering (the medical model of disease) could be seen as a continuation of more 
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subtle ‘benign’ forms of eugenics. The ‘take home message’ being that eugenics 
exists but it will take smart strategies to prevent its gradual spread. 
 
The ensuing discussion was broadly sympathetic but did raise some interesting 
questions about the kinds of parental choices which should be available. For some, the 
option of termination following testing was the best option irrespective of eugenic 
implications. Given the pro-choice orientation of the panel they largely agreed but  
defended the individual right to reject termination and the potential for support, 
education and more open approaches towards the implications of positive test results 
to impact upon such choices. This discussion did move on from the formal 
presentations and the agendas set within them with speakers being questioned and 
mildly challenged about their views. Activist participants’ calls for practical forms of 
intervention challenged the level of abstraction adopted by some speakers revealing a 
sense of underlying urgency amongst those experientially closest to the associated 
stakes.   
Human Cloning and Genetic Engineering: What’s at Stake? 
This session centred on presentations from Michael Antonio (Guys Hospital), Sarah 
Sexton (Cornerhouse), and David King (HGA). The inclusion of a practicing research 
scientist working on the nature of therapeutic and reproductive cloning marked a 
significant departure from other sessions. In these, any technical information was 
provided by the critical activist community so the ‘producer’ views characterising the 
‘Science and Citizenship’ sessions were, until this point, absent in a formal sense18. 
 
Michael Antoniou’s opening presentation as ‘sympathetic medical expert’ working as 
a gene therapist at London’s  Guy’s Hospital, gave an overview of the science. He 
focussed on the differences between reproductive and therapeutic cloning, how the 
science worked, what stem cells did and how they were created, collected, grown, and 
potentially used. This introduced a steep learning curve for some of the 15 or so 
participants with a minority demonstrating detailed knowledge through  detailed 
questions.  
 
The presentation was thus quite effective in fulfilling its main purpose of  ‘fast 
tracking’ participants in terms of the key scientific ideas and issues, enabling the 
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subsequent debate to begin from shared understandings. Other speakers were more 
critical of genetic science, emphasising its dystopian aspects and potential ‘brave new 
world’ scenarios. Some participants challenged this rhetoric, however, arguing that 
the underlying medical and scientific complexity made it an unrealisable future. Sarah 
Sexton engaged more directly with the points raised by Michael Antoniou. In 
particular, she picked up on the implicit dualisms embedded within his talk, despite 
its’ broadly ‘spot on’ remarks about the limitations of genetic research. Examples of 
these vestiges of medical culture included the ring-fencing of his own research within 
the standard ‘therapeutic good/reproductive bad’ repertoire and a largely unreflexive 
take on the question of when therapy becomes enhancement and normal variation 
becomes a medical condition. Here, both speakers sought to draw attention to the 
wider processes through which scientific research agendas are set and problems 
identified (Wynne 2005).  
Conclusions 
The European Social Forum is clearly engaged with science agendas in terms of 
overarching concerns, such as: public accountability; scrutiny of science policy; the 
effect of neo-liberalism upon research priorities and potential for proactive citizen 
science initiatives. Specific applications such as: genetics; nano-technology; GM 
crops; nuclear issues and space exploration also feature prominently. Across the 
sessions attended the same themes tended to emerge, with participants emphasising 
the problematic consequences of the relationships between neo-liberal capitalism and 
science. The prioritisation of the market context of techno-science is important 
because it suggests that  science/market  and market/politics boundaries are at least as 
important as sites for social science investigation as the science/politics boundary that 
tends to dominate the STS literature (Collins & Evans 2002). 
 
The foregrounding of market relations by actors such as Genewatch is interesting as it 
encapsulates some of the key challenges confronting all parties to the debates 
rehearsed in London. These can be formalised as: How can the benefits of scientific 
developments funded initially through the public purse deliver collective goods when 
developed in market contexts emphasising individual choice? A further question 
becomes if market approaches are to dominate implementation phases how are issues 
of democratic accountability to be best addressed? Beyond these immediate concerns 
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of both producers and consumers lies the issue of: If the other world that is possible is 
to be realised what forms of science have to be enabled?  
 
In terms of genomic science the NGO sector is clearly articulating declaratory stances 
prioritising constraints on aspects of the neo-liberal trajectory which are of immediate 
concern – even in the context of techniques with acknowledged potential benefits. 
The associated critiques of genomic science on grounds of the genetic reductionism of 
complexity overlay deeper issues of determining the actual genetic component(s) and 
generative processes in the widely accepted gene / environment / life-style matrix.  
According to Professor Johnjoe McFadden there are remarkably few causal genetic 
disorders rather, particular traits ‘represent a network peturbation generated by small, 
almost imperceptible changes in lots of genes’ (McFadden 2005).  As such systems 
biology approaches progress the claims of early market entry gene therapies could 
become subject to legal challenges of misrepresentation. This is an inescapable 
element of market approaches embodying consumer sovereignty where going to 
market with a product no one wants carries high costs (Welsh 2005). 
 
At the crux of these debates lies the question: What kind of genomic sciences do 
societies want? Here, the prospect of genomic techniques capable of monitoring the 
molecular impacts of particular chemical compounds within living organisms holds 
out the prospect of rendering Beck’s (1992) synergistic side effects tangible knowns. 
Such techniques would radically reform regulatory environments removing 
uncertainty from chains of causality associated with innumerable environmental 
pollutants for example.  
 
In part, this strategy reflects the knowledge that, when viewed historically, decisions 
about initial applications have a record that is, at best, mixed and often poor. For each 
such success story that becomes an established expressions of material culture there 
are numerous forgotten casualties and missed opportunities (see BJHS, Vol. 26, 
1993). In this sense the insistence of Genewatch and HGA that the initial promise 
associated with genomics needs to be subject to cold appraisal is redolent of other Big 
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Science break throughs where the associated triumphalism of scientifically ‘desired 
futures’ (Welsh 2000: 5-8) renders critics ‘isolated voices crying in the wilderness’19.  
 
In this context the London ESF fulfilled an important role in bringing scientific 
citizens (producers) and citizen science actors (consumers) together within a 
networked movement milieu. Interaction between these analytically imposed ‘camps’ 
was not particularly pronounced and the formal ‘outputs’ – email lists, websites and 
so on -- appear relatively modest. However this understates the importance of process 
(as opposed to product) conducive to the creation of ‘weak ties’ (Granovetter 1973) 
within networked movement. More specifically, the three European Social Forums 
held to date have cumulatively engaged with the society / science / market / politics 
problematic, and these concerns will be further refined in Greece in 2005. The process 
of network consolidation, extension and cross-over is thus on-going and the creation 
of a forum within which envisaged and unenvisaged interactions committed to 
dialogical exchange can take place is the ‘product’. 
 
Just as the emphasis on the market within the ESF raised new challenges for the 
existing STS literature, so the nascent process and dialogue within the ESF raises 
challenges for established movement approaches that seek to align movement 
interests with prevailing political opportunity structures (POS). In particular, 
prevailing POS are structured to produce dualistic ‘yes’ / ‘no’ decisions, creating the 
appearance of certainty around clearly defined interests. The account offered here 
demonstrates that clear grounds for genomic certainty are absent. Instead, the issues 
of enhancement, eugenics and the associated social risks, although formalised within 
documents  receive comparatively little attention in the science/policy debates, lying 
as they do in the future. As such, the efforts to formalise the key issues relating to this 
domain within the London ESF are features of an ‘antagonistic social movement’ 
refusing to reduce their claims through specific grievance frames in order to ‘declare 
the stakes’ to wider society (Melucci 1996). 
 
                                                 
19 This paraphrases the words of the late Lord Hinton describing his position after publicly voicing 
reservations about the future of nuclear power in the UK whilst holding office as the head of the country’s 
electricity generating utility in the late 1960s as a long anticipated reactor choice decision promised to give 
the UK dominance of  world markets (see Welsh 2000). 
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Contemporary debates on the public understanding and acceptability of science tend 
to juxtapose ‘broad and shallow’ and ‘narrow and deep’ approaches to public 
inclusion. The account offered here suggests that the increasingly permeable 
boundaries between scientific citizens and citizen scientists require another 
vocabulary of inclusion. Despite the seemingly disparate, contradictory and chaotic 
appearance of the broad picture this is the only path to embrace the diversity that 
constitutes both the social and the genetic.  Rather than broad and shallow, there is a 
need for ‘broad and diverse13’approaches.    
 
In this sense the fears articulated around disability are  material expressions of 
broader immaterial issues facing societies confronted by genomic choices that may 
incrementally reduce or eliminate the presence of ‘different others’ with unknown and 
unknowable consequences. Confronted by this, principles of social equity and justice 
represent comparatively durable means of engagement (Bauman 1993, Habermas 
2003). The principles underpinning the process orientation of the social forum 
movement are entirely consistent with such a stance and, as we have shown, the ESF 
constitutes a milieu within which such engagement is in train. Quite how these 
formalisations will progress and develop cannot be predicted.  
 
What is certain, however, is that the dialogue between scientists and citizens they 
promote provide an important and possibly unique place in which radically different 
institutional structures, principles and lives can come together. There is the potential 
here to constitute a model for another science that melds the WSF’s recognition of 
‘unity in diversity’ (Notes from Nowhere 2003), the claim that ‘Another World is 
Possible’ and ambitions within the EU to create science and technology that show 
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